Overcoming drug resistance in metastatic castration-resistant prostate cancer with novel combination of TGF-ß receptor inhibitor LY2157299 and enzalutamide: a randomized multi-site phase II study
News COVID-19 Story Tip: International Team Creates Guidelines on How to Best Virtually Assess Dizziness During Pandemic
News Liquid Biopsy Predicts Early Disease Progression, Potential Survival in Patients with Advanced Breast Cancer